CardioNet, headquartered in Pennsylvania, became an operating company in 1999, founded on an innovative, patented technology, the result of years of research and development. In the integration of cardiac monitoring, wireless communications, GPS and proprietary information management technologies, the CardioNet Mobile Cardiac Outpatient TelemetryTM (MCOTTM) system is the first to provide real-time ECG monitoring and 24/7/365 analysis and response for patients–at home, at work or traveling. In February 2002, CardioNet received FDA approval for its core monitoring technology and opened the first CardioNet Service Center in Philadelphia.
Recent NewsMore >>
DateTitle 
11/06/09CardioNet, Inc. Reports Third Quarter 2009 Financial Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Nov. 6, 2009-- CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter and nine months ended September 30, 2009. Highlights and Recent Developments Increased patient volume in the third quarter by 46.8% over the third quarter of 2008 ... 
Printer Friendly Version
10/30/09CardioNet, Inc. Provides Update on Mobile Cardiovascular Telemetry Reimbursement
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Oct. 30, 2009-- CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Centers for Medicare and Medicaid Services (“CMS”) has not established a national pricing reimbursement rate for mobile cardiovascular telemetry (CPT Code 93229) in the Medicare final rule for the physician fee schedule fo... 
Printer Friendly Version
10/28/09CardioNet Awarded its 15th U.S. Patent
Newest Patent for Biological Signal Management CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Oct. 28, 2009-- CardioNet, Inc. (NASDAQ: BEAT) announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 (“Biological Signal Management”) to CardioNet. The patent includes certain systems and techniques utilized by the Company’s Mobile Cardiac Outpatient Telemetry™ (MCOT™) system that automatically processes complex ph... 
Printer Friendly Version
10/27/09CardioNet Ranked 288th Fastest Growing Company in North America on Deloitte's 2009 Technology Fast 500
CONSHOHOCKEN, Pa., Oct 27, 2009 (BUSINESS WIRE) -- CardioNet, Inc. (NASDAQ:BEAT) announced today that it ranked 288th on Deloitte's 2009 Technology Fast 500(TM), a ranking of the 500 fastest technology, media, telecommunications, life sciences and clean technology companies in North America. The Company also announced that it ranked 13th on Deloitte's Fast 50 companies in the Greater Philadelphia region. Rankings are based on percentage of fiscal year ... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


STOCK QUOTE
BEAT (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$5.55
Change (%) Stock is Down 0.07 (1.25%)
Volume229,097
Data as of 11/06/09
4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

EMAIL ALERTS
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds
Copyright © CardioNet 2002-2009, All Rights Reservedprivacy policy/termssite mapinfo@cardionet.com